Alkylamino and aralkylamino derivatives of avarone and its mimetic as selective agents against non-small cell lung cancer cells, their antibacterial and antifungal potential
Abstract
Keywords
References
GBD 2015 Mortality and Causes of Death Collaborators, Lancet 388 (2016) 1459
L. H. Kushi, C. Doyle, M. McCullough, C. L. Rock, W. Demark-Wahnefried, E. V. Bandera, S. Gapstur, A. V. Patel, K. Andrews, T. Gansler, Ca ̶ Cancer J. Clin. 62 (2012) 30
K. Mross, F. Kratz ,in Drug Delivery in Oncology: From Basic Research to Cancer Therapy, Vol. 1, F. Kratz, P. Senter, H. Steinhagen, Eds., Wiley–VCH, Weinheim, Germany, 2011, p. 3
K. Nooter, G. Stoter, Pathol., Res. Pract. 192 (1996) 768
M. González-Ibarra, N. Farfán, C. Trejo, S. Uribe, B. Lotina-Hennsen, J. Agric. Food Chem. 53 (2005) 3415
T.-S. Lin, L.-Y. Zhu, S.-P. Xu, A. A. Divo, A. C. Sartorelli, J. Med. Chem. 34 (1991) 1634
P. S. Sarin, D. Sun, A. Thornton, W. E. G. Müller, J. Natl. Cancer Inst. 78 (1987) 663
K. Müller, A. Sellmer, W. Wiergrebe, J. Nat. Prod. 62 (1999) 1134
A. J. M. da Silva, C. D. Netto, W. Pacienza-Lima, E. C. Torres-Santos, B. Rossi-Berg-man, S. Maurel, A. Valentin, P. R. R. Costa, J. Braz. Chem. Soc. 20 (2009) 176
L.-Y. Tao, J.-Y. Zhang, Y.-J. Liang, L.-M. Chen, L.-S. Zheng, F. Wang, Y.-J. Mi, Z.-G. She, K. K. W. To, Y.-C. Lin, L.-W. Fu, Mar. Drugs 8 (2010) 1094
V. Kuete, L. K. Omosa, V. R. Sipowo Tala, J. O. Midio, A. T. Mbaveng, S. Swaleh, O. Karaosmanoğlu, H. Sivas, BMC Pharmacol. Toxicol. 17 (2016) 60
R. R. Kitagawa, W. Vilegas, I. Z. Carlos, M. S. G. Raddi, Braz. J. Pharmacogn. 21 (2011) 1084
X. Wang, B. Thomas, R. Sachdeva, L. Arteburn, L. Frye, P. G. Hatcher, D. G. Cornwell, J. Ma, Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 3604
C. S. Coates, J. Ziegler, K. Manz, J. Good, B. Kang, S. Milikisiyants, R. Chatterjee, S. Hao, J. H. Golbeck, K. V. Lakshmi, J. Phys. Chem. B 117 (2013) 7210
G. Lenaz, M. L. Genova, Biochim. Biophys. Acta, Bioenerg. 1787 (2009) 563
M. G. Traber, J. F. Stevens, Free Radical Biol. Med. 51 (2011) 1000
A. Kijjoa, P. Sawangwong, Mar. Drugs 2 (2004) 73
T. F. Molinski, D. S. Dalisay, S. L. Lievens, J. P. Saludes, Nat. Rev. Drug Discovery 8 (2009) 69
M. Gordaliza, Mar. Drugs 8 (2010) 2849
M. Jeremić, M. Pešić, J. Dinić, J. Banković, I. Novaković, D. Šegan, D. Sladić, Eur. J. Med. Chem. 118 (2016) 107
J. Vilipić, I. Novaković, T. Stanojković, I. Matić, D. Šegan, Z. Kljajić, D. Sladić, Bioorg. Med. Chem. 23 (2015) 6930
National Cancer Institute (NCI). Available from: https://www.cancer.gov/about-cancer/treatment/drugs/lung (last accessed 2018/04/10).
E. White, D. R. Green, in The molecular basis of cancer, 4th ed., J. Mendelsohn, J. W. Gray, P. M. Howley, M. A. Israel, C. B. Thompson, Eds., Elsevier Saunders, Philadelphia, PA, USA, 2015, pp. 209
G. Kroemer, L. Galluzzi, P. Vandenabeele, J. Abrams, E. S. Alnemri, E. H. Baehrecke, M. V. Blagosklonny, W. S. El-Deiry, P. Goldstein, D. R. Green. M. Hengartner, R. A. Knight, S. Kumar, S. A. Lipton, W. Malorni, G. Nuñez, M. E. Peter, J. Tschopp, J. Yuan, M. Piacentini, B. Zhivotovsky, G. Melino, Cell Death Differ. 16 (2009) 3
S. Elmore, Toxicol. Pathol. 35 (2007) 495
K. L. Rock, H. Kono, Annu. Rev. Pathol. 3 (2008) 99
L. M. Coussens, Z. Werb, Nature 420 (2002) 860
P. J. Boor, R. M. Hysmith, Toxicology 44 (1987) 129
S. Toyokuni, K. Okamoto, J. Yodoi, H. Hiai, FEBS Lett. 358 (1995) 1.
DOI: https://doi.org/10.2298/JSC180627062J
Copyright (c) 2018 J. Serb. Chem. Soc.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
IMPACT FACTOR 0.828 (140 of 172 journals)
5 Year Impact Factor 0.917 (140 of 172 journals)